Fierce competition to be seen for next generation oral anticoagulants
Published: 2012-05-10 06:57:00
Updated: 2012-05-10 06:57:00
Multinational pharmaceutical companies are stepping up their marketing in the domestic market of oral anticoagulants replacing warfarin as mainstay therapy, which is forecast to become more competitive than even, according to industry sources.
The new generation of oral anticoagulants (Bayer’s...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
